-
Things you need to know about Omicron subvariants BQ.1 and XBB
January 5, 2023
As more new variants of Omicron emerge in some overseas countries, China has also detected BQ.1 and XBB from imported cases. How virulent are these strains? Will they cause new waves of infections? Here's what Chinese experts are saying.
-
Changes to COVID management policies explained
December 28, 2022
The National Health Commission announced late Monday that it will reclassify the novel coronavirus, changing it from "novel coronavirus pneumonia" to "novel coronavirus infection".
-
Guidance on home quarantine for COVID-infected people
December 14, 2022
After three years of battling COVID-19, experts said China is seeing the light at the end of the tunnel as it continues to optimize measures against the epidemic.
-
Modified guidelines to treat virus outlined
March 23, 2022
Modifications to China's COVID-19 diagnosis and treatment guidelines are aimed at relieving strains on the medical system in the face of the highly contagious Omicron variant, officials and experts said.
-
Sites to sample nucleic acid in Tongzhou
January 18, 2022
In a bid to prevent importing COVID-19 cases during the Spring Festival travel rush, Tongzhou has set up a number of sites to sample nucleic acid.
-
Residents advised not to leave Nantong
January 10, 2022
The Nantong Center for Disease Control and Prevention has advised the city's residents to avoid leaving Nantong.
-
Notice from Nantong Center for Disease Control and Prevention
December 27, 2021
The Nantong Center for Disease Control and Prevention in Nantong, East China's Jiangsu province published notice on Dec 27 about COVID-19 prevention and control.
-
How-to China: New antibody drug to boost COVID fight
December 27, 2021
Nearly two years after the COVID-19 outbreak, China has granted emergency approval for its first antibody combination therapy for COVID-19 treatment, adding a tool to the world's arsenal against the disease.